These results demonstrate that RANK/RANKL expression patterns in BC PDXs recapitulate clinical findings and that activation of RANK signaling has pleiotropic effects in human breast adenocarcinomas. The gene discussed is TNFRSF11A; the disease is breast adenocarcinoma.